Morgan Stanley Maintains Equal-Weight on Sempra, Lowers Price Target to $76
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on Sempra (NYSE:SRE) but lowers the price target from $79 to $76.
June 24, 2024 | 4:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on Sempra but lowers the price target from $79 to $76.
The lowered price target from $79 to $76 by Morgan Stanley suggests a slightly more cautious outlook on Sempra's stock performance. This could lead to a short-term negative impact on the stock price as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100